Lupus Research Alliance News
Learning About Lupus COVID Precautions for World Health Day

April 6, 2022 The World Health Organization (WHO) designated today as World Health Day to focus global attention on threats to everyone’s health.  The COVID-19 pandemic has been such a threat and continues to endanger the health of those who are immunocompromised from disease or medical treatments such as people with lupus. To observe the […] READ MORE

Jane Salmon, MD – Determined to Help Pregnant Women Triumph Over Lupus

March 24, 2022 Recognized for her contributions to lupus during 2022’s Women’s History Month, Dr. Jane Salmon chose to specialize in lupus research because it was there that she felt she could be of greatest value.  “There were so many unknowns in lupus with all its complexity. Here was a disease primarily affecting young women […] READ MORE

Saluting Women Shaping LRA’s Strategic Scientific Direction

March 8, 2022 In honor of Women’s History Month, the LRA is saluting the three exceptional women who serve on our Scientific Advisory Board. Each is a stand-out in lupus research discovery: Mary Collins, PhD, Instructor at Harvard Medical School;  Judith James, MD, PhD, Chair of the Arthritis and Clinical Immunology Program and Lou Kerr […] READ MORE

Lupus Nephritis: A Major Focus at the Lupus Research Alliance

Updated March, 2022 Developing safe and effective treatments for lupus nephritis has been an urgent and long-standing goal in the lupus community. As the leading private funding agency for lupus research, the LRA and its legacy organizations have dedicated significant focus and resources towards addressing this continued challenge, awarding over 40 grants to address this […] READ MORE

Catch Up on LRA News with Lupus Research Update Vol. 1, 2022

February 17, 2022 It’s with great pride that I share a sampling of the many extraordinary accomplishments of last year in our first Lupus Research Update of 2022. The Lupus Research Alliance (LRA) made important gains on many fronts—thanks to tremendous friends like you. I hope you share my pride because your support continues to be the catalyst behind every LRA accomplishment. […] READ MORE

Encouraging Results with Obinutuzumab for Lupus Nephritis

February 13, 2022 The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive results as a potential treatment for lupus nephritis in the phase 2 clinical trial NOBILITY.  A medicine designed to attach a type of blood cell called B-cells with the marker CD20 on its surface, obinutuzumab […] READ MORE

Learn and connect with our community!